Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by GA Gusarova
Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Related publications
Management of Adverse Events Associated With Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
Oncology
Hematology
The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
Oncology
Hematology
Planned Pregnancy in Female Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
Oncologist
Cancer Research
Medicine
Oncology
Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
Use of Second- And Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia
Oncology and Therapy
Oncology
Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy
Haematologica
Hematology
Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology